Rajasthan Health Minister Dr Raghu Sharma on March 08 informed that COVID-19 vaccination booths will be set up in Vidhan Sabha for MLAs and their families. "COVID-19 vaccination booths will be set up in Vidhan Sabha for MLAs and their families. I've requested 60 lakh more doses. We have been assured by the Centre of receiving required doses in March," said Rajasthan Health Minister.
Children's Minister Vicky Ford says the government has been looking "really closely" at the risk of teachers catching Covid once they return to classrooms this week.
However, it found they were at no greater risk than other key workers, and would not be prioritised for the vaccine. Report by Alibhaiz. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
The district administration of Uttar Pradesh's Moradabad city has arranged a special facility for women on the occasion of International Women's Day. They commenced women special 'COVID-19 vaccination center' on March 08. The vaccination center at District Mahila Chikitsalaya is fully owned by female staff including doctors, nurses, compounders, security personnel and housekeeping staff.
As per the data released by Ministry of Health and Family Welfare (MoHFW), India on March 07 reported single-day spike of 18,711 new coronavirus cases in the last 24 hours. 100 deaths in the same period pushed the COVID-19 toll in the country to 1,57,756. India's confirmed cases of coronavirus stand at 1,12,10,799 which include 1,84,523 active infections. More than 1,08,68,520 people have recovered from the virus with 14,392 new discharges in last 24 hours. Till date the total vaccination is 2,09,22,344. According to Indian Council of Medical Research (ICMR), a total of 7,37,830 samples were tested on March 06. Cumulative samples tested for COVID-19 till March 06 are 22,14,30,507.
Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.